article thumbnail

Chemical synthesis: containment challenges for HPAPI handling

Pharmaceutical Technology

These facilities are often multi-use CMO facilities, which combined with the use of HPAPIs, require stringent containment solutions to prevent cross-contamination. Solutions for Handling Nanogram Level Potent Products to Pass Containment Testing Criteria Webinar. Chemical synthesis solutions. Free Webinar. By ILC Dover. United Kingdom.

article thumbnail

Tetra and Cellvera partner to develop oral Covid-19 treatment

Pharmaceutical Technology

Tetra Bio-Pharma and Cellvera have entered an agreement to jointly develop ARDS-003 as an oral combination therapeutic candidate with 400mg Qifenda (Favipiravir) for Covid-19. A first-in-human drug product, ARDS-003 contains the active pharmaceutical agent, Onternabez. Qifenda is a broad-spectrum antiviral drug in the commercial stage.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bromodomain Containing Protein 4 drugs in development, 2023

Pharmaceutical Technology

GlobalData’s report assesses the drugs in the Bromodomain Containing Protein 4 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

article thumbnail

The rising importance of containment in small molecule drug development

Pharmaceutical Technology

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. On the other hand, the current trend is for fully closed systems that use negative pressure to keep particles contained inside isolators.

article thumbnail

A London biotech raises $114M to hone a new ADC payload

Bio Pharma Dive

Myricx Bio is developing a type of payload that it thinks could work in tumors resistant to the toxins contained in ADCs like Enhertu and Trodelvy.

article thumbnail

Understanding the evolution of container closure integrity testing

pharmaphorum

How have drug container closure testing methods changed over time? This post explores the history and development of techniques to evaluate container integrity.

article thumbnail

How API CMOs can improve containment capabilities without facility acquisition

Pharmaceutical Technology

According to GlobalData analysis, specialist small molecule API capabilities such as containment or controlled substances are driving large contract manufacturing organisations (CMOs) to acquire facilities. Flexible containment solutions for potent APIs. Partnering with containment experts.